naltrexone has been researched along with ovalbumin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agrewala, JN; Kulkarni, SK; Raghavendra, V; Singh, V | 1 |
| Blanpied, C; Chapey, E; Dietrich, G; Jaume, M; Laffont, S | 1 |
2 other study(ies) available for naltrexone and ovalbumin
| Article | Year |
|---|---|
Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists.
Topics: Animals; Cell Line; Central Nervous System Agents; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Flumazenil; GABA-A Receptor Antagonists; Hybridomas; Immunoglobulin G; Isoquinolines; Melatonin; Mice; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Ovalbumin; Peripheral Nervous System Agents; Receptors, Opioid, mu; Th2 Cells | 2001 |
Opioid receptor blockade increases the number of lymphocytes without altering T cell response in draining lymph nodes in vivo.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Death; Cell Proliferation; Dendritic Cells; fas Receptor; Female; Flow Cytometry; Gene Expression Regulation; Genes, MHC Class II; Immunoglobulin G; Lymph Nodes; Lymphocyte Activation; Male; Mice; Mice, Inbred BALB C; Mice, Transgenic; Naltrexone; Narcotic Antagonists; Ovalbumin; Receptors, Antigen, T-Cell; Receptors, Opioid | 2007 |